These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26398827)

  • 1. Reply to "Prognostic Value of Fluorodeoxyglucose-Positron Emission Tomography".
    Kwon W; Howard BA; Herndon JE; Patz EF
    J Thorac Oncol; 2015 Oct; 10(10):e102. PubMed ID: 26398827
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic Value of FDG Uptake in Stage I Non-Small-Cell Lung Cancer: Fact or Bias?
    Girard P
    J Thorac Oncol; 2015 Oct; 10(10):e102. PubMed ID: 26398826
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic value of fluorodeoxyglucose uptake in non-small cell lung cancer: time for standardization and validation.
    Dooms C; Vansteenkiste J
    J Thorac Oncol; 2010 May; 5(5):583-4. PubMed ID: 20421763
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluorodeoxyglucose uptake predicts survival in a CT screening trial.
    Erasmus JJ
    J Thorac Oncol; 2009 Nov; 4(11):1305-6. PubMed ID: 19861902
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic value of 18F-FDG uptake on positron emission tomography in patients with pathologic stage I non-small cell lung cancer.
    Um SW; Kim H; Koh WJ; Suh GY; Chung MP; Kwon OJ; Choi JY; Han J; Lee KS; Kim J
    J Thorac Oncol; 2009 Nov; 4(11):1331-6. PubMed ID: 19701106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The maximum standardized uptake value (18)F-FDG PET is independent of the immunohistochemical expression of platelet derived endothelial growth factor in patients with non-small cell lung cancer].
    Ruibal A; Abdulkader I; Gude F; León L
    Med Clin (Barc); 2009 May; 132(16):645-6. PubMed ID: 19268326
    [No Abstract]   [Full Text] [Related]  

  • 7. Chewing gum causing a very high FDG uptake of the tongue on PET scan.
    Kathula SK; Mantil J
    Clin Nucl Med; 2007 Feb; 32(2):122-3. PubMed ID: 17242566
    [No Abstract]   [Full Text] [Related]  

  • 8. Defining radiotherapy target volumes using 18F-fluoro-deoxy-glucose positron emission tomography/computed tomography: still a Pandora's box?: in regard to Devic et al. (Int J Radiat Oncol Biol Phys 2010).
    Hatt M; Visvikis D
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1605. PubMed ID: 21092836
    [No Abstract]   [Full Text] [Related]  

  • 9. Pretreatment maximum standardized uptake value on 18F-fluorodeoxyglucose positron emission tomography is a predictor of outcome for stage I non-small cell lung cancer after stereotactic body radiotherapy.
    Tanaka H; Hayashi S; Hoshi H
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):e113-7. PubMed ID: 24176011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of anthropometric factors in 18F-FDG PET bone marrow SUVs.
    Thie JA
    J Nucl Med; 2006 Nov; 47(11):1901-2; author reply 1902. PubMed ID: 17079825
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer.
    Downey RJ; Akhurst T; Gonen M; Park B; Rusch V
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1419-27. PubMed ID: 17532932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overestimation of the prognostic significance of SUV measurement by positron emission tomography for non-small-cell lung cancer.
    Atkins CD
    J Clin Oncol; 2005 Sep; 23(27):6799-800; author reply 6800. PubMed ID: 16170191
    [No Abstract]   [Full Text] [Related]  

  • 13. Lessons from the old masters: pragmatism or purity, FDG PET SUV, serum glucose and prediction of nodal status in non-small cell lung cancer.
    Akhurst T
    J Surg Oncol; 2006 Dec; 94(7):547-8. PubMed ID: 17111390
    [No Abstract]   [Full Text] [Related]  

  • 14. [Positron emission tomography using 18F-fluorodeoxyglucose in the management of nonsmall cell lung cancers in 2006].
    Vaylet F; Bonnichon A; Salles Y; Gontier E; Bonardel G; Lefloch H; Mairovitz A; Mantzarides M; Niang A; Marotel C; Foehrenbach H
    Cancer Radiother; 2007; 11(1-2):16-22. PubMed ID: 17137819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment [18F]-fluoro-2-deoxy-glucose positron emission tomography maximum standardized uptake value as predictor of distant metastasis in early-stage non-small cell lung cancer treated with definitive radiation therapy: rethinking the role of positron emission tomography in personalizing treatment based on risk status.
    Nair VJ; MacRae R; Sirisegaram A; Pantarotto JR
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):312-8. PubMed ID: 24411602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of 18F-FDG PET avid volumes on pre-radiation therapy and post-radiation therapy FDG PET scans in recurrent lung cancer. In reply to Saraiya et al.
    Shusharina N; Sharp GC; Choi NC
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):969-70. PubMed ID: 25585791
    [No Abstract]   [Full Text] [Related]  

  • 17. Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer.
    Borst GR; Belderbos JS; Boellaard R; Comans EF; De Jaeger K; Lammertsma AA; Lebesque JV
    Eur J Cancer; 2005 Jul; 41(11):1533-41. PubMed ID: 15953716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High fluorodeoxyglucose uptake on positron emission tomography in patients with advanced non-small cell lung cancer on platinum-based combination chemotherapy.
    Lee KH; Lee SH; Kim DW; Kang WJ; Chung JK; Im SA; Kim TY; Kim YW; Bang YJ; Heo DS
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4232-6. PubMed ID: 16857796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of positron emission tomography (PET) in the staging/evaluation, treatment, and follow-up of patients with lung cancer: a critical review.
    Mac Manus M; Hicks RJ
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1298-306. PubMed ID: 19028270
    [No Abstract]   [Full Text] [Related]  

  • 20. PET/CT in non-small cell lung cancer staging-promises and problems.
    Devaraj A; Cook GJ; Hansell DM
    Clin Radiol; 2007 Feb; 62(2):97-108. PubMed ID: 17207691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.